/AEON
AEON Stock - AEON Biopharma, Inc.
Healthcare|BiotechnologyAMEX
$1.08+6.93%
+$0.07 (+6.93%) • Dec 19
78
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.19
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AEON
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.07 – $1.09
TARGET (TP)$1.24
STOP LOSS$0.99
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.75
52W High$46.66
52W Low$0.38
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $2.52M |
| Gross Profit | N/A | N/A | N/A | N/A | $2.52M |
| Gross Margin | N/A | N/A | N/A | N/A | 100.0% |
| Operating Income | $72.98M | $-348,086,000 | $-48,429,000 | $-65,847,000 | $-16,388,000 |
| Net Income | $42.01M | $-384,632,000 | $-52,556,000 | $-55,637,000 | $-32,913,000 |
| Net Margin | N/A | N/A | N/A | N/A | -1307.1% |
| EPS | $77.74 | $-4.99 | $-27.25 | $-31.73 | $-547.60 |
Company Overview
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$18
Average Target
↑ 1566.7% Upside
Now
$18
Low
$18
Average
$18
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 18th 2023 | H.C. Wainwright | Initiation | Buy | $18 |
Earnings History & Surprises
AEONBeat Rate
71%
Last 7 quarters
Avg Surprise
+26.5%
EPS vs Estimate
Beats / Misses
5/1
1 met exactly
Latest EPS
$-0.39
Q4 2025
EPS Surprise History
Q1 24
-77.5%
$-0.71vs$-0.40
Q2 24
+9.7%
$-20.14vs$-22.30
Q3 24
+15.8%
$-11.51vs$-13.67
Q4 24
0.0%
$-11.51vs$-11.51
Q1 25
+129.0%
$3.75vs$-12.95
Q2 25
+99.3%
$-0.09vs$-13.67
Q3 25
No data
Q4 25
+9.3%
$-0.39vs$-0.43
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 23, 2026 | $-0.17 | — | — | — |
Q4 2025 | Nov 14, 2025 | $-0.43 | $-0.39 | +9.3% | ✓ BEAT |
Q3 2025 | Aug 12, 2025 | — | $-0.60 | — | — |
Q2 2025 | May 14, 2025 | $-13.67 | $-0.09 | +99.3% | ✓ BEAT |
Q1 2025 | Mar 24, 2025 | $-12.95 | $3.75 | +129.0% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $-11.51 | $-11.51 | 0.0% | = MET |
Q3 2024 | Aug 12, 2024 | $-13.67 | $-11.51 | +15.8% | ✓ BEAT |
Q2 2024 | May 14, 2024 | $-22.30 | $-20.14 | +9.7% | ✓ BEAT |
Q1 2024 | Mar 29, 2024 | $-0.40 | $-0.71 | -77.5% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | — | $-40.37 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.80 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-43.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.47 | — | — |
Latest News
AEON Biopharma Executes Agreement With Daewoong Pharmaceutical To Exchange $15M Of Convertible Notes Plus Accrued Interest Into New Equity, $1.5M Of New Notes Due 2030 And Cash-Exercise Warrant For 8M Shares
📈 PositiveBenzinga•Dec 15, 2025, 09:08 PM
AEON Biopharma Announces First Closing Of PIPE Resulted In ~$1.79M In Proceeds; Says FDA BPD Type 2a Meeting Now Scheduled For January 21, 2026
📈 PositiveBenzinga•Nov 20, 2025, 01:34 PM
AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate
📈 PositiveBenzinga•Nov 14, 2025, 01:40 PM
AEON Biopharma Announces Two Complementary Transaction Of ~$22M, Eliminating Nearly All Debt
📈 PositiveBenzinga•Nov 13, 2025, 01:40 PM
AEON Biopharma Announces Biosimilarity Results Demonstrating Identical Amina Acid Sequence And Similar Functional Analysis Data Between ABP-450 And BOTOX
📈 PositiveBenzinga•Nov 13, 2025, 01:37 PM
Aegis Capital Reiterates Buy on AEON Biopharma, Maintains $7.2 Price Target
📈 PositiveBenzinga•Oct 8, 2025, 04:43 PM
FDA Schedules Biosimilar Biological Product Development Type 2a Meeting With AEON Biopharma Regarding ABP-450
➖ NeutralBenzinga•Oct 1, 2025, 12:10 PM
Frequently Asked Questions about AEON
What is AEON's current stock price?
AEON Biopharma, Inc. (AEON) is currently trading at $1.08 per share. The stock has moved +6.93% today.
What is the analyst price target for AEON?
No analyst price targets are currently available for this stock.
What sector is AEON Biopharma, Inc. in?
AEON Biopharma, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the AMEX exchange.
What is AEON's market cap?
AEON Biopharma, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does AEON pay dividends?
No, AEON Biopharma, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABP
Abpro Corporation
$5.06
Mkt Cap: $0.0B
APM
Aptorum Group Limited
$1.13
Mkt Cap: $0.0B
BOLT
Bolt Biotherapeutics, Inc.
$5.16
Mkt Cap: $0.0B
CING
Cingulate Inc.
$3.97
Mkt Cap: $0.0B
CLNN
Clene Inc.
$6.68
Mkt Cap: $0.1B
CLRB
Cellectar Biosciences, Inc.
$2.68
Mkt Cap: $0.0B
LYRA
Lyra Therapeutics, Inc.
$3.60
Mkt Cap: $0.0B
MBIO
Mustang Bio, Inc.
$1.09
Mkt Cap: $0.0B
MRKR
Marker Therapeutics, Inc.
$1.28
Mkt Cap: $0.0B
OSRH
OSR Holdings, Inc.
$0.65
Mkt Cap: $0.0B
Explore stocks similar to AEON for comparison